Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald Johann

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Imaging Informatics in Medicine|December 19, 2025
Harnessing Native-Resolution 2D Embeddings for Lung Cancer Classification: A Feasibility Study with the RAD-DINO Self-supervised Foundation ModelMd Enamul Hoq, Lawrence Tarbox, Donald Johann, et al.
Cancer Research|February 3, 2006
Discovering clinical biomarkers of ionizing radiation exposure with serum proteomic analysisCynthia Ménard, Donald Johann, Mark Lowenthal, et al.
Frontiers in Immunology|October 18, 2021
Expansion of Human Papillomavirus-Specific T Cells in Periphery and Cervix in a Therapeutic Vaccine Recipient Whose Cervical High-Grade Squamous Intraepithelial Lesion RegressedTakeo Shibata, Sumit Shah, Teresa Evans, et al.
Haematologica|May 30, 2013
Metronomic therapy is an effective salvage treatment for heavily pre-treated relapsed/refractory multiple myelomaXenofon Papanikolaou, Jackie Szymonifka, Adam Rosenthal, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 31, 2013
Patterns of central nervous system involvement in relapsed and refractory multiple myelomaAl-ola Abdallah, Shebli Atrash, Zainab Shahid, et al.
Toxicologic Pathology|June 24, 2004
Toxicoproteomics: serum proteomic pattern diagnostics for early detection of drug induced cardiac toxicities and cardioprotectionEmanuel F Petricoin, Vinodh Rajapaske, Eugene H Herman, et al.
Clinical Pharmacology and Therapeutics|August 21, 2024
Towards Preanalytical Best Practices for Liquid Biopsy Studies: A BLOODPAC Landscape AnalysisChristina M Lockwood, Jason D Merker, Elizabeth Bain, et al.
Blood|April 23, 2013
Risk factors for MDS and acute leukemia following total therapy 2 and 3 for multiple myelomaSaad Z Usmani, Jeffrey Sawyer, Adam Rosenthal, et al.
Clinical Pharmacology and Therapeutics|February 5, 2020
Minimum Technical Data Elements for Liquid Biopsy Data Submitted to Public DatabasesPhillip G Febbo, Anne-Marie Martin, Howard I Scher, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Imaging Informatics in Medicine|December 19, 2025
Harnessing Native-Resolution 2D Embeddings for Lung Cancer Classification: A Feasibility Study with the RAD-DINO Self-supervised Foundation ModelMd Enamul Hoq, Lawrence Tarbox, Donald Johann, et al.
Cancer Research|February 3, 2006
Discovering clinical biomarkers of ionizing radiation exposure with serum proteomic analysisCynthia Ménard, Donald Johann, Mark Lowenthal, et al.
Frontiers in Immunology|October 18, 2021
Expansion of Human Papillomavirus-Specific T Cells in Periphery and Cervix in a Therapeutic Vaccine Recipient Whose Cervical High-Grade Squamous Intraepithelial Lesion RegressedTakeo Shibata, Sumit Shah, Teresa Evans, et al.
Haematologica|May 30, 2013
Metronomic therapy is an effective salvage treatment for heavily pre-treated relapsed/refractory multiple myelomaXenofon Papanikolaou, Jackie Szymonifka, Adam Rosenthal, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 31, 2013
Patterns of central nervous system involvement in relapsed and refractory multiple myelomaAl-ola Abdallah, Shebli Atrash, Zainab Shahid, et al.
Toxicologic Pathology|June 24, 2004
Toxicoproteomics: serum proteomic pattern diagnostics for early detection of drug induced cardiac toxicities and cardioprotectionEmanuel F Petricoin, Vinodh Rajapaske, Eugene H Herman, et al.
Clinical Pharmacology and Therapeutics|August 21, 2024
Towards Preanalytical Best Practices for Liquid Biopsy Studies: A BLOODPAC Landscape AnalysisChristina M Lockwood, Jason D Merker, Elizabeth Bain, et al.
Blood|April 23, 2013
Risk factors for MDS and acute leukemia following total therapy 2 and 3 for multiple myelomaSaad Z Usmani, Jeffrey Sawyer, Adam Rosenthal, et al.
Clinical Pharmacology and Therapeutics|February 5, 2020
Minimum Technical Data Elements for Liquid Biopsy Data Submitted to Public DatabasesPhillip G Febbo, Anne-Marie Martin, Howard I Scher, et al.
Pageof 1